TRASTUZUMAB-ANNS

TRASTUZUMAB-ANNS was reported 1514 times

TRASTUZUMAB-ANNS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHARYNGEAL PUSTULE 1 0.2000
1 URINARY TRACT SPASM 1 0.0714
2 MAGNETIC RESONANCE IMAGING HEART 1 0.0667
3 POSITRON EMISSION TOMOGRAM 1 0.0417
4 SPECIALIST CONSULTATION 1 0.0357
5 MEDIASTINAL FIBROSIS 1 0.0238
6 VASCULAR ACCESS SITE THROMBOSIS 1 0.0200
7 XEROPHTHALMIA 8 0.0136
8 CRYOTHERAPY 1 0.0135
9 RETROPERITONEAL CANCER 1 0.0125
10 INTERCEPTED PRODUCT ADMINISTRATION ERROR 89 0.0116
11 PARANEOPLASTIC DERMATOMYOSITIS 1 0.0108
12 HER2 POSITIVE BREAST CANCER 4 0.0107
13 METASTASES TO BONE MARROW 5 0.0100
14 TRANSFERRIN DECREASED 2 0.0098
15 OSTEOCHONDROSIS 10 0.0086
16 ECHOCARDIOGRAM 1 0.0079
17 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 257 0.0076
18 LABORATORY TEST 1 0.0074
19 TESTICULAR FAILURE 1 0.0073
20 GALLBLADDER CANCER STAGE IV 1 0.0072
21 BREAST CELLULITIS 2 0.0063
22 POST PROCEDURAL CELLULITIS 1 0.0055
23 FOLATE DEFICIENCY 6 0.0052
24 RETICULOCYTE COUNT DECREASED 2 0.0046
25 PRODUCT STORAGE ERROR 346 0.0039
26 SARCOID-LIKE REACTION 1 0.0039
27 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
28 HORMONE RECEPTOR POSITIVE BREAST CANCER 1 0.0037
29 ATRIAL ENLARGEMENT 1 0.0037
30 PRODUCT CLOSURE ISSUE 2 0.0036
31 OCCUPATIONAL EXPOSURE TO PRODUCT 23 0.0036
32 INTERCEPTED PRODUCT PREPARATION ERROR 42 0.0034
33 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
34 VULVOVAGINAL DRYNESS 10 0.0031
35 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
36 BREAST HAEMORRHAGE 1 0.0030
37 RECTAL STENOSIS 1 0.0030
38 SCAN ABNORMAL 1 0.0027
39 HYPERTENSIVE HEART DISEASE 5 0.0027
40 BREAST RECONSTRUCTION 1 0.0027
41 INTERCEPTED MEDICATION ERROR 12 0.0026
42 EJECTION FRACTION ABNORMAL 3 0.0024
43 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
44 HEPATIC HAEMORRHAGE 2 0.0023
45 INTERCEPTED PRODUCT SELECTION ERROR 3 0.0023
46 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
47 PRODUCT PREPARATION ERROR 40 0.0019
48 CORONAVIRUS TEST POSITIVE 2 0.0019
49 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
50 PERIORBITAL CELLULITIS 1 0.0019
51 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
52 COLLAGEN DISORDER 1 0.0017
53 EJECTION FRACTION 1 0.0017
54 NASAL PRURITUS 2 0.0016
55 BLOOD PRESSURE MEASUREMENT 1 0.0016
56 AUTOIMMUNE COLITIS 1 0.0016
57 NEUROPATHIC ARTHROPATHY 1 0.0015
58 PRODUCT PREPARATION ISSUE 10 0.0015
59 LEFT VENTRICULAR DYSFUNCTION 10 0.0015
60 BRAIN CANCER METASTATIC 1 0.0014
61 ECHOCARDIOGRAM ABNORMAL 2 0.0014
62 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
63 CARDIAC SEPTAL DEFECT 1 0.0014
64 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
65 GENERALISED ANXIETY DISORDER 2 0.0014
66 PALLIATIVE CARE 2 0.0013
67 VEIN COLLAPSE 1 0.0013
68 MEAN CELL VOLUME DECREASED 2 0.0013
69 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
70 BREAST CANCER RECURRENT 4 0.0013
71 SKIN BACTERIAL INFECTION 1 0.0012
72 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
73 INFUSION SITE OEDEMA 1 0.0012
74 EXPOSURE TO SARS-COV-2 2 0.0012
75 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
76 MASTECTOMY 2 0.0011
77 BONE CYST 1 0.0011
78 INTRACRANIAL MASS 1 0.0011
79 ANAL CANCER 1 0.0010
80 BREAST ABSCESS 1 0.0010
81 TEETH BRITTLE 1 0.0010
82 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
83 CLAUSTROPHOBIA 1 0.0009
84 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
85 AORTIC DILATATION 1 0.0009
86 ACUTE PULMONARY OEDEMA 5 0.0009
87 LIGAMENT INJURY 1 0.0009
88 KOUNIS SYNDROME 2 0.0009
89 INTENTIONAL DOSE OMISSION 25 0.0009
90 ROSACEA 4 0.0009
91 DEVICE DISPENSING ERROR 1 0.0008
92 EOSINOPHIL COUNT DECREASED 2 0.0008
93 EJECTION FRACTION DECREASED 13 0.0008
94 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
95 LIP HAEMORRHAGE 1 0.0008
96 CANCER PAIN 2 0.0008
97 MEAN CELL VOLUME INCREASED 2 0.0008
98 BLOOD CHLORIDE DECREASED 2 0.0008
99 SKIN ODOUR ABNORMAL 3 0.0008
100 PRERENAL FAILURE 1 0.0007
101 BLOOD ELECTROLYTES DECREASED 1 0.0007
102 RESPIRATORY SYMPTOM 2 0.0007
103 NORMOCYTIC ANAEMIA 1 0.0007
104 EXCESSIVE EYE BLINKING 1 0.0007
105 HAEMOLYTIC ANAEMIA 6 0.0007
106 EMERGENCY CARE 2 0.0007
107 MOUTH INJURY 1 0.0007
108 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
109 ONYCHOLYSIS 1 0.0006
110 OSTEOSCLEROSIS 1 0.0006
111 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
112 VEIN RUPTURE 1 0.0006
113 LEFT VENTRICULAR FAILURE 2 0.0006
114 FOOD CRAVING 3 0.0006
115 FOOD POISONING 3 0.0006
116 INFUSION RELATED REACTION 36 0.0005
117 PNEUMOPERITONEUM 1 0.0005
118 PROTEIN TOTAL DECREASED 2 0.0005
119 SARS-COV-2 TEST POSITIVE 7 0.0005
120 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
121 BICYTOPENIA 1 0.0005
122 NAIL DISCOLOURATION 2 0.0005
123 GENE MUTATION 1 0.0005
124 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
125 CHILLS 58 0.0005
126 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
127 HYPERPYREXIA 2 0.0005
128 INTESTINAL PERFORATION 5 0.0004
129 FEAR OF DEATH 1 0.0004
130 ACUTE HEPATIC FAILURE 6 0.0004
131 ONYCHOCLASIS 3 0.0004
132 ISCHAEMIA 2 0.0004
133 NEUROLOGICAL DECOMPENSATION 1 0.0004
134 ORAL SURGERY 1 0.0004
135 COLORECTAL CANCER METASTATIC 1 0.0004
136 PUSTULE 1 0.0004
137 TUMOUR MARKER INCREASED 2 0.0004
138 WEIGHT ABNORMAL 1 0.0004
139 RASH VESICULAR 2 0.0004
140 ERYSIPELAS 2 0.0004
141 VASODILATATION 1 0.0004
142 ACCIDENTAL EXPOSURE TO PRODUCT 40 0.0004
143 APHTHOUS ULCER 3 0.0004
144 VENTRICULAR DYSFUNCTION 1 0.0004
145 UNEVALUABLE EVENT 29 0.0004
146 FOLLICULITIS 4 0.0004
147 LUNG OPACITY 1 0.0004
148 ADVERSE REACTION 5 0.0004
149 LARYNGOSPASM 1 0.0004
150 PNEUMONITIS 10 0.0004
151 ANAL HAEMORRHAGE 1 0.0004
152 ATYPICAL FEMUR FRACTURE 1 0.0004
153 NEUTROPHIL COUNT ABNORMAL 1 0.0004
154 OXYGEN SATURATION ABNORMAL 1 0.0004
155 HAEMATOLOGICAL MALIGNANCY 1 0.0004
156 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
157 TOOTH DISCOLOURATION 1 0.0003
158 INFUSION SITE REACTION 1 0.0003
159 CENTRAL VENOUS CATHETERISATION 1 0.0003
160 LIP DRY 3 0.0003
161 DUODENITIS 1 0.0003
162 DIARRHOEA HAEMORRHAGIC 3 0.0003
163 INFUSION SITE PRURITUS 1 0.0003
164 THERAPEUTIC RESPONSE CHANGED 2 0.0003
165 LOOSE TOOTH 1 0.0003
166 HEPATIC NEOPLASM 1 0.0003
167 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
168 CIRCULATORY COLLAPSE 5 0.0003
169 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
170 BREAST CANCER METASTATIC 3 0.0003
171 SENSITIVE SKIN 2 0.0003
172 LABORATORY TEST ABNORMAL 8 0.0003
173 CARDIAC DYSFUNCTION 1 0.0003
174 SNORING 1 0.0003
175 CHEMOTHERAPY 1 0.0003
176 ADVERSE EVENT 24 0.0003
177 UNINTENTIONAL MEDICAL DEVICE REMOVAL 3 0.0003
178 REHABILITATION THERAPY 1 0.0003
179 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
180 GASTROINTESTINAL INFLAMMATION 2 0.0003
181 NEUROPATHY PERIPHERAL 24 0.0003
182 POLYNEUROPATHY 3 0.0003
183 PRODUCT ADMINISTRATION ERROR 5 0.0002
184 RECURRENT CANCER 1 0.0002
185 ANAPHYLACTOID REACTION 1 0.0002
186 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
187 DISEASE PROGRESSION 28 0.0002
188 PRODUCT DOSE OMISSION ISSUE 69 0.0002
189 VITAMIN D DECREASED 2 0.0002
190 METASTATIC NEOPLASM 1 0.0002
191 HORDEOLUM 1 0.0002
192 ILL-DEFINED DISORDER 14 0.0002
193 DIVERTICULUM INTESTINAL 1 0.0002
194 NAIL DISORDER 2 0.0002
195 COLD SWEAT 4 0.0002
196 GINGIVAL SWELLING 1 0.0002
197 LYMPHOCYTE COUNT DECREASED 4 0.0002
198 BLOOD CREATINE INCREASED 1 0.0002
199 CARDIOTOXICITY 2 0.0002
200 VASCULAR DEVICE INFECTION 1 0.0002
201 IMMUNE THROMBOCYTOPENIA 1 0.0002
202 LOCALISED OEDEMA 1 0.0002
203 NEPHROGENIC ANAEMIA 1 0.0002
204 FEELING COLD 6 0.0002
205 UMBILICAL HERNIA 1 0.0002
206 BRONCHOSPASM 3 0.0002
207 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
208 HOSPICE CARE 2 0.0002
209 PROTEIN URINE PRESENT 1 0.0002
210 ANAPHYLACTIC REACTION 11 0.0002
211 TOXIC SKIN ERUPTION 2 0.0002
212 VULVOVAGINAL PRURITUS 1 0.0002
213 BODY TEMPERATURE INCREASED 4 0.0002
214 FAILURE TO THRIVE 1 0.0002
215 TENDERNESS 2 0.0002
216 CYANOSIS 3 0.0002
217 GINGIVITIS 1 0.0002
218 BACK INJURY 2 0.0002
219 JAW DISORDER 1 0.0002
220 TACHYCARDIA 16 0.0002
221 HEART RATE ABNORMAL 1 0.0002
222 MACULAR OEDEMA 1 0.0002
223 OXYGEN SATURATION DECREASED 10 0.0002
224 MITRAL VALVE INCOMPETENCE 2 0.0002
225 DYSGEUSIA 13 0.0002
226 NEUTROPHIL COUNT DECREASED 7 0.0002
227 PRODUCT LABEL CONFUSION 1 0.0002
228 BLOOD IRON DECREASED 2 0.0002
229 DERMATITIS ACNEIFORM 1 0.0002
230 TENSION 1 0.0002
231 PHOTOPSIA 1 0.0002
232 CHEST DISCOMFORT 16 0.0002
233 PROCTALGIA 1 0.0002
234 HAEMOGLOBIN ABNORMAL 1 0.0002
235 INFUSION SITE PAIN 2 0.0002
236 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
237 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
238 MUCOSAL INFLAMMATION 4 0.0002
239 PULMONARY CONGESTION 2 0.0002
240 HAEMATOCRIT DECREASED 3 0.0002
241 APPETITE DISORDER 1 0.0002
242 CARDIAC FAILURE ACUTE 1 0.0001
243 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
244 BLOOD BILIRUBIN INCREASED 4 0.0001
245 ULCER HAEMORRHAGE 1 0.0001
246 TACHYPNOEA 2 0.0001
247 GINGIVAL BLEEDING 2 0.0001
248 DROOLING 1 0.0001
249 ADVERSE DRUG REACTION 13 0.0001
250 LYMPHOEDEMA 1 0.0001
251 HYPERTRANSAMINASAEMIA 1 0.0001
252 PULMONARY TOXICITY 1 0.0001
253 METASTASIS 1 0.0001
254 THERAPY INTERRUPTED 10 0.0001
255 RASH PUSTULAR 1 0.0001
256 MAJOR DEPRESSION 1 0.0001
257 UTERINE LEIOMYOMA 1 0.0001
258 TRANSAMINASES INCREASED 3 0.0001
259 HEPATOTOXICITY 3 0.0001
260 HYDRONEPHROSIS 1 0.0001
261 PAROSMIA 1 0.0001
262 HEPATOCELLULAR CARCINOMA 1 0.0001
263 OFF LABEL USE 115 0.0001
264 HYPERTHERMIA 1 0.0001
265 ACIDOSIS 1 0.0001
266 DEVICE ADHESION ISSUE 2 0.0001
267 HYPOALBUMINAEMIA 1 0.0001
268 THERAPY PARTIAL RESPONDER 2 0.0001
269 BRAIN FOG 2 0.0001
270 CARDIAC FAILURE 10 0.0001
271 ATRIAL FIBRILLATION 12 0.0001
272 SHOCK HAEMORRHAGIC 1 0.0001
273 PLATELET COUNT DECREASED 13 0.0001
274 EPISTAXIS 9 0.0001
275 AGEUSIA 3 0.0001
276 CARDIOVASCULAR DISORDER 3 0.0001
277 ILLNESS 12 0.0001
278 BLOOD MAGNESIUM DECREASED 1 0.0001
279 ANAEMIA 22 0.0001
280 METASTASES TO LIVER 2 0.0001
281 PRODUCT COMMUNICATION ISSUE 1 0.0001
282 LUNG INFILTRATION 1 0.0001
283 RASH 49 0.0001
284 ISCHAEMIC STROKE 2 0.0001
285 BACK PAIN 26 0.0001
286 MYOSITIS 1 0.0001
287 DRY MOUTH 9 0.0001
288 DYSPNOEA 62 0.0001
289 EXOSTOSIS 1 0.0001
290 RESPIRATORY DISTRESS 3 0.0001
291 TREMOR 18 0.0001
292 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
293 FLANK PAIN 1 0.0001
294 INCREASED APPETITE 2 0.0001
295 AFFECT LABILITY 1 0.0001
296 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
297 HAEMORRHOIDS 2 0.0001
298 SURGERY 6 0.0001
299 THERAPY CHANGE 1 0.0001
300 BLADDER DISORDER 1 0.0001
301 BLOOD PRESSURE ABNORMAL 2 0.0001
302 DIARRHOEA 64 0.0001
303 STOMATITIS 6 0.0001
304 DRY SKIN 13 0.0001
305 TEMPERATURE INTOLERANCE 1 0.0001
306 POOR VENOUS ACCESS 1 0.0001
307 VENTRICULAR EXTRASYSTOLES 1 0.0001
308 EYE DISCHARGE 1 0.0001
309 PULMONARY HYPERTENSION 2 0.0001
310 UNDERDOSE 7 0.0001
311 WEIGHT FLUCTUATION 1 0.0001
312 TRANSFUSION 1 0.0001
313 KNEE ARTHROPLASTY 2 0.0001
314 FULL BLOOD COUNT ABNORMAL 1 0.0001
315 RETCHING 2 0.0001
316 LIVER FUNCTION TEST INCREASED 2 0.0001
317 ASTHENIA 35 0.0001
318 PHARYNGITIS STREPTOCOCCAL 1 0.0001
319 PRODUCT DISPENSING ERROR 2 0.0001
320 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
321 TOOTH FRACTURE 1 0.0001
322 FEBRILE NEUTROPENIA 6 0.0001
323 LIP SWELLING 3 0.0001
324 MALNUTRITION 1 0.0001
325 BLOOD CALCIUM DECREASED 1 0.0001
326 MYOCARDIAL ISCHAEMIA 1 0.0001
327 MYOCARDITIS 1 0.0001
328 PRODUCT SUBSTITUTION ISSUE 5 0.0001
329 MUSCLE TWITCHING 2 0.0001
330 ELECTROLYTE IMBALANCE 1 0.0001
331 BONE PAIN 5 0.0001
332 BLOOD PRESSURE FLUCTUATION 2 0.0001
333 MALAISE 36 0.0001
334 CYTOPENIA 1 0.0001
335 CARDIOMEGALY 1 0.0001
336 GENERALISED OEDEMA 1 0.0001
337 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
338 HOT FLUSH 6 0.0001
339 ACNE 6 0.0001
340 HEPATITIS 2 0.0001
341 GASTROINTESTINAL DISORDER 7 0.0001
342 HIATUS HERNIA 1 0.0001
343 PALPITATIONS 9 0.0001
344 CHEST PAIN 14 0.0001
345 EAR INFECTION 2 0.0001
346 QUALITY OF LIFE DECREASED 1 0.0001
347 OEDEMA 4 0.0001
348 NEUTROPENIA 10 0.0001
349 INFLUENZA LIKE ILLNESS 6 0.0001
350 ABDOMINAL PAIN UPPER 15 0.0001
351 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
352 HYPOMAGNESAEMIA 1 0.0001
353 WOUND 2 0.0001
354 DEVICE OCCLUSION 1 0.0001
355 HYPERTENSION 15 0.0001
356 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
357 SINUS TACHYCARDIA 1 0.0001
358 VOMITING 33 0.0001
359 RED BLOOD CELL COUNT DECREASED 2 0.0001
360 ANGINA PECTORIS 2 0.0001
361 LETHARGY 4 0.0001
362 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
363 NAUSEA 54 0.0001
364 ASCITES 2 0.0001
365 RESPIRATORY DISORDER 2 0.0001
366 BLOOD POTASSIUM DECREASED 2 0.0001
367 LACRIMATION INCREASED 2 0.0001
368 DIZZINESS 33 0.0001
369 FATIGUE 51 0.0001
370 BLOOD PRESSURE INCREASED 10 0.0001
371 HYPERSENSITIVITY 12 0.0001
372 LIMB DISCOMFORT 2 0.0001
373 ANKLE FRACTURE 1 0.0001
374 BREAST CANCER 6 0.0001
375 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
376 OBESITY 1 0.0001
377 COVID-19 11 0.0001
378 DRUG INTOLERANCE 6 0.0001
379 IMPAIRED HEALING 2 0.0001
380 MULTIPLE FRACTURES 1 0.0001
381 PHOTOSENSITIVITY REACTION 1 0.0001
382 DEHYDRATION 8 0.0001
383 FACE OEDEMA 1 0.0001
384 FLUSHING 6 0.0001
385 HEPATIC ENZYME INCREASED 4 0.0001
386 HOSPITALISATION 9 0.0001
387 THERAPY CESSATION 3 0.0001
388 MUSCULOSKELETAL DISCOMFORT 1 0.0001
389 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
390 NEUROTOXICITY 1 0.0001
391 AMENORRHOEA 1 0.0001
392 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
393 DRUG ERUPTION 1 0.0001
394 GALLBLADDER DISORDER 1 0.0001
395 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
396 OSTEOMYELITIS 1 0.0001
397 PELVIC PAIN 1 0.0001
398 PYREXIA 19 0.0001
399 OROPHARYNGEAL PAIN 5 0.0001
400 CONJUNCTIVITIS 1 0.0001
401 AGRANULOCYTOSIS 1 0.0001
402 URTICARIA 9 0.0001
403 PHOTOPHOBIA 1 0.0001
404 DYSPNOEA EXERTIONAL 2 0.0001
405 MYALGIA 9 0.0001
406 SLEEP APNOEA SYNDROME 1 0.0001
407 PULMONARY FIBROSIS 1 0.0001
408 ACUTE RESPIRATORY FAILURE 1 0.0001
409 HERNIA 1 0.0001
410 EAR PAIN 1 0.0001
411 ORAL HERPES 1 0.0001
412 NASAL CONGESTION 3 0.0001
413 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
414 HEART RATE INCREASED 5 0.0001
415 SYNCOPE 5 0.0000
416 COUGH 14 0.0000
417 CYTOKINE RELEASE SYNDROME 1 0.0000
418 FEEDING DISORDER 1 0.0000
419 PLEURAL EFFUSION 3 0.0000
420 TASTE DISORDER 1 0.0000
421 OEDEMA PERIPHERAL 6 0.0000
422 HEADACHE 29 0.0000
423 PRURITUS GENERALISED 1 0.0000
424 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
425 AMNESIA 3 0.0000
426 BLOOD CREATININE INCREASED 3 0.0000
427 ACUTE KIDNEY INJURY 7 0.0000
428 PERIPHERAL SWELLING 7 0.0000
429 TOOTH DISORDER 1 0.0000
430 RASH MACULO-PAPULAR 1 0.0000
431 HYPOTENSION 9 0.0000
432 ORAL PAIN 1 0.0000
433 THERAPY NON-RESPONDER 2 0.0000
434 PAIN IN EXTREMITY 13 0.0000
435 MUSCLE SPASMS 8 0.0000
436 TINNITUS 2 0.0000
437 SHOCK 1 0.0000
438 HYPOKALAEMIA 2 0.0000
439 SEIZURE 5 0.0000
440 PERICARDIAL EFFUSION 1 0.0000
441 DISEASE RECURRENCE 2 0.0000
442 BLOOD GLUCOSE DECREASED 2 0.0000
443 LOCALISED INFECTION 1 0.0000
444 CONSTIPATION 9 0.0000
445 PRESYNCOPE 1 0.0000
446 ALOPECIA 8 0.0000
447 DYSPEPSIA 4 0.0000
448 OSTEONECROSIS OF JAW 1 0.0000
449 CELLULITIS 2 0.0000
450 PRODUCT COMPLAINT 1 0.0000
451 HYPOPHAGIA 1 0.0000
452 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
453 HYPERHIDROSIS 5 0.0000
454 INFLAMMATION 2 0.0000
455 DIPLOPIA 1 0.0000
456 RESPIRATORY TRACT INFECTION 1 0.0000
457 NERVOUSNESS 2 0.0000
458 MUSCULOSKELETAL PAIN 2 0.0000
459 GASTRITIS 1 0.0000
460 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
461 BREAST CANCER FEMALE 1 0.0000
462 PAIN OF SKIN 1 0.0000
463 FREQUENT BOWEL MOVEMENTS 1 0.0000
464 THROAT TIGHTNESS 1 0.0000
465 RASH PRURITIC 2 0.0000
466 MEDICATION ERROR 2 0.0000
467 HAEMOPTYSIS 1 0.0000
468 PANCYTOPENIA 2 0.0000
469 THROMBOCYTOPENIA 4 0.0000
470 HYPONATRAEMIA 2 0.0000
471 PAIN IN JAW 1 0.0000
472 ACUTE MYOCARDIAL INFARCTION 1 0.0000
473 WHEEZING 2 0.0000
474 CORONARY ARTERY DISEASE 1 0.0000
475 VERTIGO 2 0.0000
476 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
477 VISUAL IMPAIRMENT 4 0.0000
478 WEIGHT DECREASED 9 0.0000
479 SWOLLEN TONGUE 1 0.0000
480 PARAESTHESIA 5 0.0000
481 NIGHT SWEATS 1 0.0000
482 PNEUMONIA 10 0.0000
483 DECREASED APPETITE 7 0.0000
484 BLOOD PRESSURE DECREASED 2 0.0000
485 EXPIRED PRODUCT ADMINISTERED 1 0.0000
486 VIRAL INFECTION 1 0.0000
487 FUNGAL INFECTION 1 0.0000
488 SKIN DISORDER 1 0.0000
489 GAIT INABILITY 1 0.0000
490 ABDOMINAL DISCOMFORT 5 0.0000
491 TYPE 2 DIABETES MELLITUS 1 0.0000
492 GASTRIC DISORDER 1 0.0000
493 ARTHRALGIA 12 0.0000
494 DEVICE USE ERROR 1 0.0000
495 NEOPLASM PROGRESSION 1 0.0000
496 HAEMORRHAGE 3 0.0000
497 RASH MACULAR 1 0.0000
498 HYPERKALAEMIA 1 0.0000
499 HYPOXIA 1 0.0000
500 CEREBRAL HAEMORRHAGE 1 0.0000
501 MYELOSUPPRESSION 1 0.0000
502 INFECTION 4 0.0000
503 RESPIRATORY FAILURE 2 0.0000
504 ACCIDENTAL OVERDOSE 1 0.0000
505 DYSURIA 1 0.0000
506 EYE SWELLING 1 0.0000
507 INTESTINAL OBSTRUCTION 1 0.0000
508 COLITIS 1 0.0000
509 CHRONIC KIDNEY DISEASE 2 0.0000
510 PAIN 16 0.0000
511 THROMBOSIS 2 0.0000
512 BLINDNESS 1 0.0000
513 LUNG NEOPLASM MALIGNANT 1 0.0000
514 ERYTHEMA 5 0.0000
515 OSTEOPOROSIS 1 0.0000
516 CARDIAC ARREST 2 0.0000
517 POLLAKIURIA 1 0.0000
518 RENAL IMPAIRMENT 2 0.0000
519 OSTEOARTHRITIS 1 0.0000
520 URINARY TRACT INFECTION 4 0.0000
521 PRURITUS 9 0.0000
522 RECTAL HAEMORRHAGE 1 0.0000
523 SEPTIC SHOCK 1 0.0000
524 PULMONARY OEDEMA 1 0.0000
525 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
526 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
527 NEPHROLITHIASIS 1 0.0000
528 ABDOMINAL PAIN 5 0.0000
529 CARDIAC DISORDER 2 0.0000
530 ARRHYTHMIA 1 0.0000
531 OCULAR HYPERAEMIA 1 0.0000
532 PULMONARY EMBOLISM 2 0.0000
533 MIGRAINE 2 0.0000
534 PRODUCTIVE COUGH 1 0.0000
535 FEELING ABNORMAL 5 0.0000
536 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
537 CONTUSION 2 0.0000
538 INTERSTITIAL LUNG DISEASE 1 0.0000
539 DRY EYE 1 0.0000
540 LEUKOPENIA 1 0.0000
541 SOMNOLENCE 4 0.0000
542 FLUID RETENTION 1 0.0000
543 SINUSITIS 2 0.0000
544 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
545 BRADYCARDIA 1 0.0000
546 INSOMNIA 5 0.0000
547 TREATMENT NONCOMPLIANCE 1 0.0000
548 NECK PAIN 1 0.0000
549 BLISTER 1 0.0000
550 EYE PAIN 1 0.0000
551 HERPES ZOSTER 1 0.0000
552 NO ADVERSE EVENT 3 0.0000
553 FEELING HOT 1 0.0000
554 NASOPHARYNGITIS 3 0.0000
555 GAIT DISTURBANCE 3 0.0000
556 RHINORRHOEA 1 0.0000
557 DEEP VEIN THROMBOSIS 1 0.0000
558 DEVICE DIFFICULT TO USE 1 0.0000
559 FALL 5 0.0000
560 NEOPLASM MALIGNANT 1 0.0000
561 VISION BLURRED 2 0.0000
562 MEMORY IMPAIRMENT 2 0.0000
563 BURNING SENSATION 1 0.0000
564 DEVICE MALFUNCTION 1 0.0000
565 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
566 ANXIETY 4 0.0000
567 SKIN BURNING SENSATION 1 0.0000
568 MOBILITY DECREASED 1 0.0000
569 AGITATION 1 0.0000
570 WEIGHT INCREASED 3 0.0000
571 HYPOAESTHESIA 2 0.0000
572 INCORRECT DOSE ADMINISTERED 3 0.0000
573 DRUG DOSE OMISSION BY DEVICE 1 0.0000
574 ARTHRITIS 1 0.0000
575 CARDIAC FAILURE CONGESTIVE 1 0.0000
576 CONFUSIONAL STATE 2 0.0000
577 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
578 SKIN EXFOLIATION 1 0.0000
579 DEATH 10 0.0000
580 BALANCE DISORDER 1 0.0000
581 INTENTIONAL PRODUCT MISUSE 1 0.0000
582 MUSCULOSKELETAL STIFFNESS 1 0.0000
583 DEVICE ISSUE 1 0.0000
584 SWELLING 1 0.0000
585 PRODUCT USE ISSUE 2 0.0000
586 BLOOD GLUCOSE INCREASED 2 0.0000
587 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
588 HAEMOGLOBIN DECREASED 1 0.0000
589 OVERDOSE 2 0.0000
590 INFLUENZA 1 0.0000
591 ASTHMA 1 0.0000
592 RHEUMATOID ARTHRITIS 1 0.0000
593 MUSCULAR WEAKNESS 1 0.0000
594 DEPRESSION 2 0.0000
595 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
596 JOINT SWELLING 1 0.0000
597 EMOTIONAL DISTRESS 1 0.0000
598 LOSS OF CONSCIOUSNESS 1 0.0000
599 RENAL FAILURE 1 0.0000
600 PRODUCT QUALITY ISSUE 1 0.0000
601 CONDITION AGGRAVATED 2 0.0000
602 CEREBROVASCULAR ACCIDENT 1 0.0000
603 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
604 DRUG INEFFECTIVE 1 0.0000